Advanced MR Imaging of the Abdomen

October 28–30, 2010
Seville, ES

In order to register, please click here:

Course organiser:
Nicholas Gourtsoyiannis / Iraklion, GR

Local organiser:
Luis Martí-Bonmatí / Valencia, ES
Antonio Talegón / Seville, ES

Course venue:
Hospitales Universitarios Virgen del Rocío
Edificio de Gobierno
Avenida Manuel Siurot s/n
ES - 41013 Sevilla

Preliminary faculty:
R. Beets-Ton, N. Gourtsoyiannis, Th. Helmberger,
L. Martí-Bonmatí, C. Matos, N. Papanikolaou, R. Pozzi-Mucelli, H.P. Schlemmer, B. Van Beers

Course duration:
Thursday noon – Saturday noon

Programme:
Please click here to download the programme as PDF.


Tha aim of this course:
The course aims to convey an in-depth knowledge about MR imaging of the abdomen. The topics covered include modern MRI techniques and updated MR applications for diagnosing focal and diffuse liver disease as well as recent developments in MR imaging of the pancreas and biliary tract. The course also focuses on MR imaging of the GI tract, the kidneys, adrenal glands, prostate and bladder. A team of renowned teachers with expert knowledge in abdominal imaging ensures a high quality teaching programme and looks forward to welcoming you in Seville.

Participation Requirements:
Physicians who have attended the School of MRI Applied MR Techniques courses or have good knowledge in MR techniques from other sources; minimum of 6 months experience in applied MRI of the Abdomen.

Learning Objectives

MR Imaging Technique
• Pulse sequences for body applications
• Image quality: problems and solutions
• Diffusion, perfusion imaging
• MR spectroscopy
• Parallel imaging

MR Imaging of Focal Liver Lesions
• Appearance on T1-weighted sequences
• Role of in- and opposed phase imaging
• Appearance on T2-weighted sequences with short TE
• Appearance on T2-weighted sequences with long TE
• Enhancement patterns of cysts, hemangiomas, metastases, FNH, adenomas, and HCC
• Role of SPIO- and Manganese-enhanced imaging

MR Imaging of Diffuse Hepatic Parenchymal Disease and HCC
• Diffuse fatty infiltration, focal non-steatosis, hemosidersis,
hemochromatosis, cirrhosis, portal hypertension, collateral routes, ascites, regenerative nodules, dysplastic nodules, diffuse and focal manifestations of HCC
• Appearance on T1-weighted sequences
• Role of in- and opposed phase imaging
• Role of T1-weighted sequences with long TE
• Appearance on T2-weighted sequences
• Enhancement patterns of cysts, hemangiomas, metastases, FNH, adenomas, and HCC
• Role of SPIO- and Manganese-enhanced imaging

MRCP
• Currently used 2D and 3D techniques
• Post-processing of the source images
• Major indications and MR imaging findings
• functional studies using secretin and biliary contrast agents
• Role of MRCP in the current clinical practice
• MRCP versus ERCP

MR Imaging of Pancreatic Lesions
• Appearance of the normal pancreas and tumours on T1-weighted sequences
• Appearance of the normal pancreas and tumours on T2-weighted sequences with short TE
• Enhancement patterns of focal pancreatitis versus pancreatic tumours
• Staging of pancreatic tumours
• contribution of diffusion-weighted imaging

MR Imaging of the Kidneys and Adrenal Glands
• Appearance of the normal kidneys and adrenals on T1-, and T2-weighted images
• The enhancement patterns of the renal and adrenal masses
• Characteristics of the renal tumours, including RCC, adenomas, angiomyolipomas, etc.
• Staging of the RCC, including the diameter of the lesions, and extra-renal and vascular extension
• In- and opposed-phase imaging
• Malignant adrenal tumours

MR Imaging of the Small Intestine
• Intraluminal contrast agents
• Route of contrast administration
• MR enteroclysis technique
• Normal appearances
• Familiarity with MRE imaging findings
• Crohn disease activity

MR Imaging of the Prostate and Bladder
• Appearance of the normal prostate and tumours on T1- and T2-weighted images
• The enhancement patterns of benign and malignant lesions
• Prostate carcinoma and the relationship to PSA: current concepts and controversies
• MR spectroscopy

MR Imaging of Anorectal Diseases
• To understand the evidence and perspectives in rectal cancer MRI
• To understand the role of MR staging in respect to other imaging modalities
• To understand the MR rectal protocol and what clinicians want to know from us